Sjors M. Kas - Concepedia

Author

Sjors M. Kas

The Netherlands Cancer Institute ORCID

Also Known As

S. Kas, Sjors Kas, Sjors M Kas, Sjors M. Kas

Publications

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Cancer Genomics Centre Oncode Institute Delft University of Technology Wellcome Sanger Institute

About

Sjors M. Kas is an author at The Netherlands Cancer Institute specializing in tumor biology, medicine, and cancer biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	776
2	Cell Biology	4	4	292
3	Immunology	3	3	691
4	Engineering	1	1	146
5	Molecular Biology	1	1	146

Sjors M. Kas

Publications

991

Citations

H-Index

Page 1

	Year	Citations
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis Max D. Wellenstein, Seth B. Coffelt, Danique E. M. Duits, Nature InflammationBreast Cancer MetastasisBreast OncologyMedicineImmunology	2019	484
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland Stefano Annunziato, Sjors M. Kas, Micha Nethe, Genes & Development EngineeringImmunologyMolecular BiologyCrispr/cas9 SystemCancer Biology	2016	146
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, Nature	2022	124
Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma Sjors M. Kas, Julian R. de Ruiter, Koen Schipper, Nature Genetics Systems BiologyBreast OncologyInsertional MutagenesisMedicineOncogenic Agent	2017	72
Fusicoccin-A selectively induces apoptosis in tumor cells after interferon-α priming Ingrid J. de Vries-van Leeuwen, Chantal Kortekaas-Thijssen, Jean A. Nzigou Mandouckou, Cancer Letters Cancer ResearchMedicineApoptosisImmunologyCell Death	2010	61
High-throughput semiquantitative analysis of insertional mutations in heterogeneous tumors Marco J. Koudijs, Christiaan Klijn, Louise van der Weyden, Genome Research	2011	39
Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547 Sjors M. Kas, Julian R. de Ruiter, Koen Schipper, Cancer Research	2018	36
Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system Sjoerd Klarenbeek, Chris W. Doornebal, Sjors M. Kas, OncoImmunology	2020	16
Identifying transposon insertions and their effects from RNA-sequencing data Julian R. de Ruiter, Sjors M. Kas, Eva Schut, Nucleic Acids Research GeneticsGenomicsGene Expression ProfilingTumor BiologyTransposon Insertions	2017	13

Page 1